A Study of What is Different in People with Alopecia Areata that Makes T cells Attack Hair Follicles
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 12-004980
Sponsor Protocol Number: 12-004980
About this study
This study is being done to try to figure out what is different in people with Alopecia Areata that makes the T cells attack hair follicles.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
AA Patients
- Subjects must have Alopecia Areata, Alopecia Totalis or Alopecia Universalis, and no immunodeficiency or cancer (although coincidence of other autoimmune diseases could still qualify for inclusion)
- Subjects should not be pregnant or be on systemic corticosteroids
- Subjects of any age, race, or gender will be included as long as they are able to provide informed consent
Control samples
- For all control subjects
- Individuals must have no history of AA
- No immunodeficiency or cancer
- Subjects should not be pregnant or be on systemic corticosteroids
- Subjects of any age, race, or gender will be included as long as they are able to provide informed consent
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Adam Schrum, Ph.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available